FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 20:50:15 28/06/2024 BST | ||
| 2.06 EUR | 0.00% |
|
| Current month | -3.74% | ||
| 1 month | -6.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 2.06 | 0.00% |
| 27/06/24 | 2.06 | 0.00% |
| 26/06/24 | 2.06 | +4.57% |
| 25/06/24 | 1.97 | -1.99% |
| 24/06/24 | 2.01 | -4.29% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 08:50 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB0QMA |
| ISIN | DE000SB0QMA7 |
| Date issued | 04/06/2020 |
| Strike | 223.6 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.98 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.27 € |
|---|---|
| Lowest since issue | 1.91 € |
| Spread | 0.01 € |
| Spread % | 0.48% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
